HomeJohnson & Johnson

  • J&J stops trial of BACE for Alzheimer’s disease to enter the list of failed drugs

    • May 19, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Esketamine improves outcomes in Treatment-Resistant Depression patients, new Phase 3 data shows

    • May 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more